Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Maruff

Showing results (261-270 of 438) with videos related to

Pageof 44
Sort By:
Psychological Science|May 27, 2021
Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older AdultsKarra D Harrington, Andrew J Aschenbrenner, Paul Maruff, et al.
Journal of Immunology Research|August 11, 2020
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with IpilimumabAnne Rogiers, Christophe Leys, Justine Lauwyck, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 3, 2018
Online study partner-reported cognitive decline in the Brain Health RegistryRachel L Nosheny, Monica R Camacho, Philip S Insel, et al.
Biological Psychiatry|February 18, 2019
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B<sub>12</sub>, B<sub>6</sub>, and Folic Acid on Symptoms and Neurocognition in First-Episode PsychosisKelly Allott, Patrick D McGorry, Hok Pan Yuen, et al.
Psychiatry Research|September 5, 2006
Evaluating brain activity in obsessive-compulsive disorder: preliminary insights from a multivariate analysisBen J Harrison, Murat Yücel, Marnie Shaw, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Epilepsy & Behavior : E&B|February 9, 2025
Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistanceJacob Pellinen, Stefan Sillau, Chris Morrison, et al.
Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.
Pageof 44

Showing results (261-270 of 438) with videos related to

Sort By:
Pageof 44
Psychological Science|May 27, 2021
Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older AdultsKarra D Harrington, Andrew J Aschenbrenner, Paul Maruff, et al.
Journal of Immunology Research|August 11, 2020
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with IpilimumabAnne Rogiers, Christophe Leys, Justine Lauwyck, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 3, 2018
Online study partner-reported cognitive decline in the Brain Health RegistryRachel L Nosheny, Monica R Camacho, Philip S Insel, et al.
Biological Psychiatry|February 18, 2019
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B<sub>12</sub>, B<sub>6</sub>, and Folic Acid on Symptoms and Neurocognition in First-Episode PsychosisKelly Allott, Patrick D McGorry, Hok Pan Yuen, et al.
Psychiatry Research|September 5, 2006
Evaluating brain activity in obsessive-compulsive disorder: preliminary insights from a multivariate analysisBen J Harrison, Murat Yücel, Marnie Shaw, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Epilepsy & Behavior : E&B|February 9, 2025
Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistanceJacob Pellinen, Stefan Sillau, Chris Morrison, et al.
Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.
Pageof 44